Early suppression policies protected pregnant women from COVID ‐19 in 2020: A population‐based surveillance from the Nordic countries
Acta Obstetricia et Gynecologica Scandinavica · 2024
DOI: 10.1111/aogs.14808 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Acta Obstetricia et Gynecologica Scandinavica, 2024. Verfasst von Reetta Varpula und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Helsinki University Hospital and Helsinki University, Helsinki, Finland. Hauptthemen laut MEDLINE: COVID-19, Pregnancy Complications, Infectious, SARS-CoV-2. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The Region of Southern Denmark and Region Zealand's shared fund for joint health research projects, NFOG fund, Suomen Lääketieteen Säätiö.
Abstract (Originalsprache)
Introduction
The Coronavirus 2019 Disease (COVID‐19) pandemic reached the Nordic countries in March 2020. Public health interventions to limit viral transmission varied across different countries both in timing and in magnitude. Interventions indicated by an Oxford Stringency Index ≥50 were implemented early (March 13–17, 2020) in Denmark, Finland, Norway and Iceland, and on March 26, 2020 in Sweden. The aim of the current study was to assess the incidence of COVID‐19‐related admissions of pregnant women in the Nordic countries in relation to the different national public health strategies during the first year of the pandemic. Material and methods This is a meta‐analysis of population‐based cohort studies in the five Nordic countries with national or regional surveillance in the Nordic Obstetric Surveillance System (NOSS) collaboration: national data from Denmark, Finland, Iceland and Norway, and regional data covering 31% of births in Sweden. The source population consisted of women giving birth in the included areas March 1–December 31, 2020. Pregnant women with a positive SARS‐CoV‐2 PCR test ≤14 days before hospital admission were included, and admissions were stratified as either COVID‐19‐related or non‐COVID (other obstetric healthcare). Information about public health policies was retrieved retrospectively.
Results
In total, 392 382 maternities were considered. Of these, 600 women were diagnosed with SARS‐CoV‐2 infection and 137 (22.8%) were admitted for COVID‐19 symptoms. The pooled incidence of COVID‐19 admissions per 1000 maternities was 0.5 (95% confidence interval [CI] 0.2 to 1.2, I 2 = 77.6, tau 2 = 0.68, P = 0.0), ranging from no admissions in Iceland to 1.9 admissions in the Swedish regions. Interventions to restrict viral transmission were less stringent in Sweden than in the other Nordic countries.
Conclusions
There was a clear variation in pregnant women's risk of COVID‐19 admission across countries with similar healthcare systems but different public health interventions to limit viral transmission. The meta‐analysis indicates that early suppression policies protected pregnant women from severe COVID‐19 disease prior to the availability of individual protection with vaccines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Helsinki University Hospital and Helsinki University, Helsinki, Finland.
- Department of Obstetrics and Gynecology, Copenhagen University Hospital-Holbæk, Holbæk, Denmark.
- Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
- Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.
- Department for Health Promotion, Norwegian Institute of Public Health, Bergen, Norway.
- Department of Obstetrics and Gynecology, Sahlgrenska University Hospital, Gothenburg, Sweden.
ORCID-Profile: Reetta Varpula, Outi Äyräs, Anna J M Aabakke, Teresia Svanvik, Camilla Tjønneland Mentzoni, Siri Vangen, Karin Källén, Aura Pyykönen, Lone Krebs, Hilde Marie Engjom
Förderung
- The Region of Southern Denmark and Region Zealand's shared fund for joint health research projects
- NFOG fund
- Suomen Lääketieteen Säätiö
- Norges Forskningsråd
Zitieren
APA
Varpula, R., Äyräs, O., Aabakke, A. J. M., Klungsøyr, K., Svanvik, T., Kanerva, J., Jonasdottir, E., Mentzoni, C. T., Thurn, L., Jones, E., Fredriksson, L., Pettersson, K., Nyfløt, L. T., Vangen, S., Røe, K., Júlíusson, P. B., Källén, K., Gissler, M., Pyykönen, A., …, & Engjom, H. M. (2024). Early suppression policies protected pregnant women from COVID ‐19 in 2020: A population‐based surveillance from the Nordic countries. Acta Obstetricia et Gynecologica Scandinavica. https://doi.org/10.1111/aogs.14808
Vancouver
Varpula R, Äyräs O, Aabakke AJM, Klungsøyr K, Svanvik T, Kanerva J, et al. Early suppression policies protected pregnant women from COVID ‐19 in 2020: A population‐based surveillance from the Nordic countries. Acta Obstetricia et Gynecologica Scandinavica. 2024. doi:10.1111/aogs.14808
BibTeX
@article{Varpula2024,
author = {Varpula, Reetta and Äyräs, Outi and Aabakke, Anna J M and Klungsøyr, Kari and Svanvik, Teresia and Kanerva, Julia and Jonasdottir, Eva and Mentzoni, Camilla Tjønneland and Thurn, Lars and Jones, Elin and Fredriksson, Lisa and Pettersson, Karin and Nyfløt, Lill Trine and Vangen, Siri and Røe, Kjerstine and Júlíusson, Pétur B and Källén, Karin and Gissler, Mika and Pyykönen, Aura and Jakobsson, Maija and Krebs, Lone and Engjom, Hilde Marie},
title = {Early suppression policies protected pregnant women from COVID ‐19 in 2020: A population‐based surveillance from the Nordic countries},
journal = {Acta Obstetricia et Gynecologica Scandinavica},
year = {2024},
doi = {10.1111/aogs.14808}
}
EUVIMED